Literature DB >> 25920319

Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus.

Kendra J Alfson1, Laura E Avena2, Michael W Beadles2, Heather Menzie1, Jean L Patterson2, Ricardo Carrion2, Anthony Griffiths1.   

Abstract

Sudan virus (SUDV), like the closely related Ebola virus (EBOV), is a filovirus that causes severe hemorrhagic disease. They both contain an RNA editing site in the glycoprotein gene that controls expression of soluble and full-length protein. We tested the consequences of cell culture passage on the genome sequence at the SUDV editing site locus and determined whether this affected virulence. Passage resulted in expansion of the SUDV editing site, similar to that observed with EBOV. We compared viruses possessing either the wild-type or expanded editing site, using a nonhuman primate model of disease. Despite differences in virus serum titer at one time point, there were no significant differences in time to death or any other measured parameter. These data imply that changes at this locus were not important for SUDV lethality.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  RNA editing; Sudan virus; cell culture adaptation; editing site; glycoprotein

Mesh:

Substances:

Year:  2015        PMID: 25920319      PMCID: PMC6283357          DOI: 10.1093/infdis/jiv216

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Authors:  Z Y Yang; H J Duckers; N J Sullivan; A Sanchez; E G Nabel; G J Nabel
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 3.  Ebola virus pathogenesis: implications for vaccines and therapies.

Authors:  Nancy Sullivan; Zhi-Yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  A new approach to determining whole viral genomic sequences including termini using a single deep sequencing run.

Authors:  Kendra J Alfson; Michael W Beadles; Anthony Griffiths
Journal:  J Virol Methods       Date:  2014-07-27       Impact factor: 2.014

5.  Processing of the Ebola virus glycoprotein by the proprotein convertase furin.

Authors:  V E Volchkov; H Feldmann; V A Volchkova; H D Klenk
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 6.  Rapid evolution of RNA genomes.

Authors:  J Holland; K Spindler; F Horodyski; E Grabau; S Nichol; S VandePol
Journal:  Science       Date:  1982-03-26       Impact factor: 47.728

7.  Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

Authors:  Nathalie Alazard-Dany; Valentina Volchkova; Olivier Reynard; Caroline Carbonnelle; Olga Dolnik; Michèle Ottmann; Alexander Khromykh; Viktor E Volchkov
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

8.  Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture.

Authors:  F Sobrino; M Dávila; J Ortín; E Domingo
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

9.  Shed GP of Ebola virus triggers immune activation and increased vascular permeability.

Authors:  Beatriz Escudero-Pérez; Valentina A Volchkova; Olga Dolnik; Philip Lawrence; Viktor E Volchkov
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

10.  Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure.

Authors:  Masfique Mehedi; Thomas Hoenen; Shelly Robertson; Stacy Ricklefs; Michael A Dolan; Travis Taylor; Darryl Falzarano; Hideki Ebihara; Stephen F Porcella; Heinz Feldmann
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823

View more
  11 in total

1.  Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.

Authors:  Mingkui Zhou; Michael Humbert; Muhammad M Mukhtar; Hanna B Scinto; Hemant K Vyas; Samir K Lakhashe; Siddappa N Byrareddy; Gregor Maurer; Swati Thorat; Joshua Owuor; Zhao Lai; Yidong Chen; Anthony Griffiths; Agnès-Laurence Chenine; Sanjeev Gumber; François Villinger; David Montefiori; Ruth M Ruprecht
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

2.  Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.

Authors:  Dylan M Johnson; Jenny D Jokinen; Min Wang; Tia Pfeffer; Irina Tretyakova; Ricardo Carrion; Anthony Griffiths; Peter Pushko; Igor S Lukashevich
Journal:  Vaccine       Date:  2020-02-25       Impact factor: 3.641

3.  Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.

Authors:  Hanna B Scinto; Sandeep Gupta; Swati Thorat; Muhammad M Mukhtar; Anthony Griffiths; Jennifer Delgado; Elizabeth Plake; Hemant K Vyas; Amanda Strickland; Siddappa N Byrareddy; David C Montefiori; Celia LaBranche; Ranajit Pal; Jim Treece; Sharon Orndorff; Maria Grazia Ferrari; Deborah Weiss; Agnes-Laurence Chenine; Robert McLinden; Nelson Michael; Jerome H Kim; Merlin L Robb; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Ruth M Ruprecht
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 4.  Distinct Genome Replication and Transcription Strategies within the Growing Filovirus Family.

Authors:  Adam J Hume; Elke Mühlberger
Journal:  J Mol Biol       Date:  2019-06-29       Impact factor: 5.469

5.  A Single Amino Acid Change in the Marburg Virus Glycoprotein Arises during Serial Cell Culture Passages and Attenuates the Virus in a Macaque Model of Disease.

Authors:  Kendra J Alfson; Laura E Avena; Jenny Delgado; Michael W Beadles; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  mSphere       Date:  2018-01-03       Impact factor: 4.389

6.  A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Authors:  Benoit Callendret; Jort Vellinga; Kerstin Wunderlich; Ariane Rodriguez; Robin Steigerwald; Ulrike Dirmeier; Cedric Cheminay; Ariane Volkmann; Trevor Brasel; Ricardo Carrion; Luis D Giavedoni; Jean L Patterson; Chad E Mire; Thomas W Geisbert; Jay W Hooper; Mo Weijtens; Jutta Hartkoorn-Pasma; Jerome Custers; Maria Grazia Pau; Hanneke Schuitemaker; Roland Zahn
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

7.  Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material.

Authors:  John C Trefry; Suzanne E Wollen; Farooq Nasar; Joshua D Shamblin; Steven J Kern; Jeremy J Bearss; Michelle A Jefferson; Taylor B Chance; Jeffery R Kugelman; Jason T Ladner; Anna N Honko; Dean J Kobs; Morgan Q S Wending; Carol L Sabourin; William D Pratt; Gustavo F Palacios; M Louise M Pitt
Journal:  Viruses       Date:  2015-12-19       Impact factor: 5.048

8.  Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus/H.sapiens-tc/COD/1995/Kikwit-9510621 Challenge Stock "R4368" and Its Replacement "R4415".

Authors:  Jeffrey R Kugelman; Cynthia A Rossi; Michael R Wiley; Jason T Ladner; Elyse R Nagle; Bradley P Pfeffer; Karla Garcia; Karla Prieto; Jiro Wada; Jens H Kuhn; Gustavo Palacios
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

9.  Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.

Authors:  Shannon L M Whitmer; Jason T Ladner; Michael R Wiley; Ketan Patel; Gytis Dudas; Andrew Rambaut; Foday Sahr; Karla Prieto; Samuel S Shepard; Ellie Carmody; Barbara Knust; Dhamari Naidoo; Gibrilla Deen; Pierre Formenty; Stuart T Nichol; Gustavo Palacios; Ute Ströher
Journal:  Cell Rep       Date:  2018-01-30       Impact factor: 9.423

10.  Intramuscular Exposure of Macaca fascicularis to Low Doses of Low Passage- or Cell Culture-Adapted Sudan Virus or Ebola Virus.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Gabriella Worwa; Melanie Amen; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  Viruses       Date:  2018-11-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.